Alexandra Voutsina

1.4k total citations
31 papers, 1.2k citations indexed

About

Alexandra Voutsina is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Alexandra Voutsina has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Alexandra Voutsina's work include Lung Cancer Treatments and Mutations (12 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Research Studies (8 papers). Alexandra Voutsina is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Research Studies (8 papers). Alexandra Voutsina collaborates with scholars based in Greece, United Kingdom and Sweden. Alexandra Voutsina's co-authors include Vassilis Georgoulias, John Souglakos, Aristea Kalikaki, Dimitris Mavroudis, Anastasios Koutsopoulos, Efstathios N. Stathopoulos, Maria Trypaki, D. Mavroudis, Maria Tzardi and Maria Sfakianaki and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Alexandra Voutsina

31 papers receiving 1.2k citations

Peers

Countries citing papers authored by Alexandra Voutsina

Since Specialization

Citations

This map shows the geographic impact of Alexandra Voutsina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Voutsina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Voutsina more than expected).

Fields of papers citing papers by Alexandra Voutsina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Voutsina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Voutsina. The network helps show where Alexandra Voutsina may publish in the future.

Co-authorship network of co-authors of Alexandra Voutsina

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Voutsina. A scholar is included among the top collaborators of Alexandra Voutsina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Voutsina. Alexandra Voutsina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1277P HRD status of patients with early stage non-small cell lung cancer 2023 ·Annals of Oncology ·Apostolos Klinakis, (unknown), Alexandra Voutsina, (unknown), Κonstantinos Potaris, (unknown), Katerina Tsilingiri, Ioannis Vamvakaris, (unknown), (unknown), (unknown), Pantelis Constantoulakis, Αthanasios Kotsakis, Vassilis Georgoulias	1
2	Prognostic Value of KRAS Mutations in Colorectal Cancer Patients 2022 ·Cancers ·(unknown), (unknown), Ippokratis Messaritakis, Maria Sfakianaki, Alexandra Voutsina, Maria Trypaki, (unknown), Evangelos Koustas, Michalis V. Karamouzis, (unknown), Anna Koumarianou, Nikolaos Androulakis, Dimitriοs Mavroudis, Maria Tzardi, John Souglakos	41
3	Synergy of Hir1, Ssn6, and Snf2 global regulators is the functional determinant of a Mac1 transcriptional switch in S. cerevisiae copper homeostasis 2019 ·Current Genetics ·Alexandra Voutsina, (unknown), Kalliopi Gkouskou, Despina Alexandraki	4
4	Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer 2018 ·PLoS ONE ·Ippokratis Messaritakis, (unknown), (unknown), Maria Sfakianaki, Alexandra Voutsina, (unknown), Elias Athanasakis, Evangelos Xynos, Dimitris Mavroudis, Maria Tzardi, John Souglakos	42
5	ESR1 Methylation: A Liquid Biopsy–Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment 2017 ·Clinical Cancer Research ·Sofia Mastoraki, Αreti Strati, Eleni Tzanikou, Maria Chimonidou, Eleni Politaki, Alexandra Voutsina, Amanda Psyrri, Vassilis Georgoulias, Evi Lianidou	126
6	Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer 2017 ·Translational Oncology ·Alexios Matikas, Alexandra Voutsina, Eleni Lagoudaki, Dora Hatzidaki, Maria Trypaki, (unknown), Maria Tzardi, Dimitriοs Mavroudis, (unknown)	7
7	Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors 2017 ·Clinical & Translational Oncology ·Filippos Koinis, Alexandra Voutsina, Aristea Kalikaki, Anastasios Koutsopoulos, Eleni Lagoudaki, (unknown), Eleftheria‐Kleio Dermitzaki, (unknown), Athanasios Pallis, Vassilis Georgoulias, Αthanasios Kotsakis	2
8	Role of circulating free DNA in colorectal cancer 2016 ·World Journal of Gastrointestinal Oncology ·Alexios Matikas, Alexandra Voutsina, Maria Trypaki, Vassilis Georgoulias	6
9	ERCC1SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy 2015 ·Cancer Investigation ·Aristea Kalikaki, Alexandra Voutsina, Anastasios Koutsopoulos, Chara Papadaki, Maria Sfakianaki, (unknown), Alexandros Xyrafas, Αthanasios Kotsakis, Sofia Agelaki, John Souglakos, Dimitriοs Mavroudis, Vassilis Georgoulias	12
10	KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer 2014 ·PLoS ONE ·Aristea Kalikaki, (unknown), John Souglakos, Stella Apostolaki, (unknown), Nefeli Georgoulia, Maria Tzardi, Dimitris Mavroudis, Vassilis Georgoulias, Alexandra Voutsina	36
11	PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer 2014 ·British Journal of Cancer ·Chara Papadaki, Maria Sfakianaki, Eleni Lagoudaki, (unknown), Georgios Ioannidis, Maria Trypaki, (unknown), Alexandra Voutsina, Anastasios Koutsopoulos, Dimitriοs Mavroudis, Vassilis Georgoulias, John Souglakos	51
12	Excision-repair-cross-complement-1 protein as a prognostic factor in patients with advanced non-small cell lung cancer treated with platinum-based first-line chemotherapy 2013 ·Lung Cancer ·(unknown), Efstathios N. Stathopoulos, (unknown), Anastasios Koutsopoulos, Alexandra Voutsina, Vassilis Georgoulias, Dimitris Mavroudis	11
13	Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer 2012 ·Modern Pathology ·Alexandra Voutsina, Maria Tzardi, Aristea Kalikaki, Zafeiris Zafeiriou, (unknown), Michael Papadakis, Dimitris Mavroudis, Vassilis Georgoulias	50
14	No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: A meta-analysis 2010 ·Lung Cancer ·Ming Yin, (unknown), Alexandra Voutsina, Carmelo Tibaldi, David C. Christiani, Rebecca S. Heist, Rafael Rosell, Richard Booton, Qingyi Wei	45
15	Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status 2009 ·Lung Cancer ·Aristea Kalikaki, Anastasios Koutsopoulos, Dora Hatzidaki, Maria Trypaki, (unknown), Efstathios N. Stathopoulos, Dimitris Mavroudis, Vassilis Georgoulias, Alexandra Voutsina	76
16	Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC 2008 ·British Journal of Cancer ·Aristea Kalikaki, Anastasios Koutsopoulos, Maria Trypaki, John Souglakos, Efstathios N. Stathopoulos, Vassilis Georgoulias, D. Mavroudis, Alexandra Voutsina	182
17	‘Classical’ but not ‘other’ mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer 2007 ·British Journal of Cancer ·Athanasios Pallis, Alexandra Voutsina, (unknown), John Souglakos, Evangelos Briasoulis, Samuel Murray, Anastasios Koutsopoulos, (unknown), Efstathios N. Stathopoulos, D. Mavroudis, Vassilis Georgoulias	74
18	P3-157: Correlation of EGFR mutation status between primary tumor and metastases in NSCLC 2007 ·Journal of Thoracic Oncology ·(unknown), Alexandra Voutsina, Anastasios Koutsopoulos, Athanasios Pallis, Maria Trypaki, John Souglakos, Efstathios N. Stathopoulos, Dimitriοs Mavroudis, Vassilis Georgoulias	1
19	The second cysteine‐rich domain of Mac1p is a potent transactivator that modulates DNA binding efficiency and functionality of the protein 2001 ·FEBS Letters ·Alexandra Voutsina, (unknown), Alexandra Boutla, Despina Alexandraki	10
20	Sequence divergence of the RNA polymerase shared subunit ABC14.5 (Rpb8) selectively affects RNA polymerase III assembly in Saccharomyces cerevisiae 1999 ·Nucleic Acids Research ·Alexandra Voutsina	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact